Trisha Shetty (Editor)

Tefibazumab

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Type
  
Whole antibody

Target
  
Clumping factor A

ATC code
  
none

Source
  
Humanized (from mouse)

Trade names
  
Aurexis

CAS Number
  
521079-87-8

Tefibazumab (named Aurexis but not approved) is a humanized monoclonal antibody for the treatment of severe infections with Staphylococcus aureus. Possible indications include the treatment of S. aureus in a phase 2a patients with cystic fibrosis and of methicillin-resistant S. aureus.

It was developed by Inhibitex.

References

Tefibazumab Wikipedia